Chronic opioid use following surgery for head and neck cancer patients undergoing free flap reconstruction

• Published in: Journal of otolaryngology Vol. 50; no. 1; p. 28
• Main Authors: Hinther, Ashley, Rasool, Alysha, Nakoneshny, Steven C, Chandarana, Shamir P, Hart, Robert, Matthews, T Wayne, Dort, Joseph C
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 23.04.2021; Sage Publications Ltd; BioMed Central; SAGE Publications
• Subjects: Adjuvant treatment; Age; Alcohol use; Analgesics; Cancer; Cancer patients; Cancer therapies; Care and treatment; Ethics; Head & neck cancer; Head and neck cancer; Head and neck surgery; Morphine; Narcotics; Oncology, Experimental; Opioids; Original; Pain; Pain management; Patients; Pharmacy; Postoperative opioid use; Postoperative pain; Prescription drugs; Risk factors; Smoking; Surgery; Tobacco; Canada; Alberta Canada; United States > US; Postoperative opioid use; Postoperative pain; Head and neck surgery; Opioids
• ISSN: 1916-0216; 1916-0208; 1916-0216
• DOI: 10.1186/s40463-021-00508-y

Physician opioid-prescribing patterns have significant impacts on the current opioid crisis. Patients who use opioids in the postoperative period are at risk of developing chronic postoperative opioid use. This study determined the rate of chronic postoperative opioid use among head and neck cancer patients undergoing primary surgery with free-flap reconstruction. Additionally, this study identified major risk factors associated with the development of chronic postoperative opioid use. A retrospective chart review was performed for all adults (age ≥ 18 years) undergoing primary head and neck surgical resection with free-flap reconstruction between January 2008 and December 2015. Patients were identified from a prospectively collected database, Otobase™. Data from the provincial drug insurance program were used to capture drug dispensing information to determine chronic opioid use at 3- and 12-months postoperatively. Data extracted from Otobase™ included patient demographics, social habits, clinical stage, pathological stage, type of surgery, and adjuvant treatment. The total cohort was comprised of 212 patients. Chronic opioid use at 3- and 12- months postoperatively was observed in 136 (64%) and 116 (55%) patients, respectively. Of the 212 patients, 85 patients (40%) were identified as preoperative opioid users and 127 were opioid naïve (60%). Of the 85 patients who were preoperative opioid users, 70 (82%) and 63 (77%) patients continued to use opioids 3- and 12-months postoperatively, respectively. The proportion of opioid-naïve patients who were using opioids at 3- and 12-months postoperatively was 52% (66 patients) and 42% (53 patients), respectively. Identified risk factors included preoperative opioid use, prior tobacco use, advanced pathologic T-stage, and adjuvant treatment. Among head and neck cancer patients that have undergone major resection with free-flap reconstruction, the prevalence of chronic postoperative opioid users was considerable. Identified risk factors included preoperative opioid use, prior tobacco use, tumor stage, and adjuvant treatment.